International Ovarian Tumor Analysis (IOTA) Simple Rules Risk Assessment
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Benign—
- Malignant—
- Inconclusive—
The International Ovarian Tumor Analysis (IOTA) Simple Rules Risk Assessment calculates predicting risk of malignancy in adnexal masses using ultrasonographic features. Key inputs include unilocular cyst. Scores guide determining delivery timing, administering antenatal corticosteroids or tocolytics, and obstetric monitoring. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Predicts risk of malignancy in adnexal masses using ultrasonographic features. The IOTA Simple Rules use 10 ultrasound features (5 benign B-rules and 5 malignant M-rules) to classify ovarian masses as benign, malignant, or inconclusive. This classification system achieves 86.8% sensitivity, 95.6% specificity, and 92.3% accuracy in distinguishing benign from malignant ovarian tumors. The rules are designed for preoperative evaluation of persistent adnexal masses in women considered for surgery, excluding classical masses with pathognomonic features (corpus luteum, endometrioma, dermoid cyst).
Clinical Indication
The International Ovarian Tumor Analysis (IOTA) Simple Rules Risk Assessment is indicated for bedside clinical practice to support Predicts risk of malignancy in adnexal masses using ultrasonographic features. The IOTA Simple Rules use 10 ultrasound features (5 benign B-rules and 5 malignant M-rules) to classify ovarian masses as benign, malignant, or inconclusive. This classification system achieves 86.8% sensitivity, 95.6% specificity, and 92.3% accuracy in distinguishing benign from malignant ovarian tumors. The rules are designed for preoperative evaluation of persistent adnexal masses in women considered for surgery, excluding classical masses with pathognomonic features (corpus luteum, endometrioma, dermoid cyst).. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Pregnant individuals across antepartum, intrapartum, and postpartum stages, or patients with acute gynecologic conditions. Clinical application is indicated across Labor and delivery suites, obstetric triage, antenatal clinics, and gynecologic surgical units.
Limitations & Contraindications
Normal gestational physiological adaptations alter baseline plasma volume, serum creatinine, and resting heart rate. Clinical exclusion: Excludes classical masses with pathognomonic features (corpus luteum, endometrioma, dermoid cyst).
Clinical Pearls & Action Plan
Simultaneous surveillance of maternal hemodynamic stability and continuous electronic fetal heart rate monitoring is paramount. Guideline pearl: The IOTA Simple Rules achieved 86.8% sensitivity, 95.6% specificity, and 92.3% accuracy.
If B-features present AND no M-features → Benign; If M-features present AND no B-features → Malignant; If both present OR neither present → Inconclusive
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| unilocular_cyst | string | Yes | B1 - Unilocular cyst (single chamber with smooth wall) |
| solid_components_small | string | Yes | B2 - Solid components <7mm in largest diameter |
| acoustic_shadows | string | Yes | B3 - Acoustic shadows (hyperechoic areas with shadowing suggesting calcifications or fat) |
| smooth_multilocular_small | string | Yes | B4 - Smooth multilocular tumor <100mm in largest diameter |
| no_blood_flow | string | Yes | B5 - No blood flow on color Doppler (color score 1) |
| irregular_solid_tumor | string | Yes | M1 - Irregular solid tumor (completely solid mass with irregular outline) |
| ascites | string | Yes | M2 - Ascites (free fluid in the abdomen) |
| papillary_structures | string | Yes | M3 - At least 4 papillary structures (solid projections into cystic cavity) |
| irregular_multilocular_large | string | Yes | M4 - Irregular multilocular solid tumor with largest diameter ≥100mm |
| strong_blood_flow | string | Yes | M5 - Very strong blood flow on color Doppler (color score 4) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| — | Benign | One or more B-features present, no M-features |
| — | Malignant | One or more M-features present, no B-features |
| — | Inconclusive | Both B-features and M-features present, or no features present |
Evidence-Based References (EBM)
- Timmerman D, Testa AC, Bourne T, et al. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group. J Clin Oncol. 2005 Dec 1;23(34):8794-801. doi: 10.1200/JCO.2005.01.7632.DOI: 10.1200/JCO.2005.01.7632
- Timmerman D, Ameye L, Fischerova D, et al. Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation study. BMJ. 2010 Dec 14;341:c6839. doi: 10.1136/bmj.c6839.DOI: 10.1136/bmj.c6839
- Nunes N, Ambler G, Foo X, et al. Use of IOTA simple rules for diagnosis of ovarian cancer: meta-analysis. Ultrasound Obstet Gynecol. 2014 Nov;44(5):503-14. doi: 10.1002/uog.13437.DOI: 10.1002/uog.13437